Literature DB >> 3371866

Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis.

U Spengler1, G R Pape, R M Hoffmann, J P Johnson, J Eisenburg, G Paumgartner, G Riethmüller.   

Abstract

To study the expression of MHC Class II subregion gene products on biliary epithelial cells in primary biliary cirrhosis, frozen sections from liver biopsies of 15 patients with primary biliary cirrhosis were studied immunohistochemically using HLA-D subregion specific monoclonal antibodies L243 (HLA-DR), Leu10 (HLA-DQ) and B7/21 (HLA-DP). Patients with early stages of primary biliary cirrhosis showed expression of HLA-DP, HLA-DR and HLA-DQ subregion gene products on bile duct epithelial cells. In advanced stages of disease, no MHC Class II antigens or only HLA-DR and HLA-DP were expressed on bile duct cells. While normal hepatocytes did not express detectable amounts of MHC Class II antigens, hepatocytes from liver biopsies of four patients with primary biliary cirrhosis showed a distinct staining exclusively with monoclonal antibodies specific for HLA-DR. The expression of MHC Class II antigens on parenchymal cells was independent of a lymphocytic infiltration into the tissue. This study demonstrates that bile ductular cells, but not hepatocytes, express a full set of MHC Class II molecules at least during the early stages of primary biliary cirrhosis. We propose, therefore, that the expression of both HLA-DR and HLA-DQ subregion products on bile duct epithelial cells may be a necessary, although not sufficient, condition for the initiation of an autoimmune process leading to the destruction of intrahepatic bile ducts in primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371866     DOI: 10.1002/hep.1840080304

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis.

Authors:  K Inamura; H Tsuji; Y Nakamoto; M Suzuki; S Kaneko
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 2.  Mitochondrial antigens and antibodies in primary biliary cirrhosis.

Authors:  P Butler; F Valle; A K Burroughs
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

3.  Plasma membrane association of primary biliary cirrhosis mitochondrial marker antigen M2.

Authors:  U Sundin; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

4.  Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis.

Authors:  R M Hoffmann; G R Pape; U Spengler; E P Rieber; J Eisenburg; J Döhrmann; G Paumgartner; G Riethmüller
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

5.  Antibody binding and inhibition of pyruvate dehydrogenase (PDH) in sera from patients with primary biliary cirrhosis.

Authors:  U Sundin
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

6.  Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion.

Authors:  Merlin Airik; Blake McCourt; Tugba Tastemel Ozturk; Amy B Huynh; Xiaoyi Zhang; Justin T Tometich; Rezan Topaloglu; Hasan Ozen; Diclehan Orhan; Kari Nejak-Bowen; Satdarshan P Monga; Timothy W Hand; Fatih Ozaltin; Rannar Airik
Journal:  FASEB J       Date:  2022-02       Impact factor: 5.834

7.  Endothelial cell damage in primary biliary cirrhosis: influence of cholestasis and immunological mechanisms.

Authors:  A D Blann; C Babbs; J M Neuberger
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

8.  Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.

Authors:  S Bloom; K Fleming; R Chapman
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

9.  The global and promoter-centric 3D genome organization temporally resolved during a circadian cycle.

Authors:  Masami Ando-Kuri; Rodrigo G Arzate-Mejía; Mayra Furlan-Magaril; Jörg Morf; Jonathan Cairns; Abraham Román-Figueroa; Luis Tenorio-Hernández; A César Poot-Hernández; Simon Andrews; Csilla Várnai; Boo Virk; Steven W Wingett; Peter Fraser
Journal:  Genome Biol       Date:  2021-06-08       Impact factor: 13.583

10.  HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.

Authors:  S Shimoda; M Nakamura; H Ishibashi; K Hayashida; Y Niho
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.